Simple structural chromosomal abnormalities in advanced stage of ovarian cancer

In Vivo

Volumn 23, Issue 3, 2009, Pages 425-428

  Panani, Anna D ^a   Aravidis, Christos ^a   Kosmaidou, Zoe ^b   Rodolakis, Alexandros ^a   Antsaklis, Aristides ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Department of Genetics ^*

Author keywords

Acquired pericentric inversion 9; Chromosomes; G banding; Ovarian cancer; Simple structural chromosomal abnormalities

Indexed keywords

ARTICLE; ASCITES FLUID; CANCER STAGING; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CHROMOSOME XQ; CLONE; CYTOGENETICS; HUMAN; OVARY CANCER; STRUCTURAL CHROMOSOME ABERRATION; TUMOR CELL;

EID: 67649697758     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lynch HT, Casey MJ, Lynch J, White T and Godwin AK: Genetics and ovarian carcinoma. Semin Oncol 25: 265-280, 1998.
2. Wang N: Cytogenetics and molecular genetics of ovarian cancer. Am J Med Genet (Semin Med Genet) 115: 157-163, 2002.
3. Taetle R, Aickin M, Yang J-M, Panda L, Emerson J, Roe D, Adair L, Thompson F, Liu Y, Wisner L, Davis JR, Trent J and Alberts DS: Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes Cancer 25: 290-300, 1999.
4. Panani AD and Roussos C: Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality. Cancer Lett 235: 130-135, 2006.
5. Panani AD and Ferti A: Common marker chromosomes in ovarian cancer. Cancer Genet Cytogenet 16: 65-71, 1985.
6. Panani AD: Preferential involvement of chromosome 11 as add(ll)(pl5) in ovarian cancer: is it a common cytogenetic abnormality in cancer? Cancer Lett 258: 262-267, 2007.
7. Israeli O, Gotlieb WH, Friedman E, Korach J, Friedman E, Goldman B, Zeltser A, Ben-Baruch G, Rienstein S and Aviram-Goldring A: Genomic analyses of primary and metastatic serous epithelial ovarian cancer. Cancer Genet Cytogenet 154: 16-21, 2004.
8. Bayani J, Brenton JD, Macgrecor PF, Beheshti B, Albert M, Nallainathan D, Karaskova J, Rosen B, Murphy J, Laframboise S, Zanke B and Squire JA: Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridisation and expression microarrays. Cancer Res 62: 3466-3476,2002.
9. Hu J, Khanna V, Jones MW and Surti U: Comparative study of primary and recurrent ovarian serous carcinomas: Comparative genomic hybridisation analysis with a potential application for prognosis. Gynecol Oncol 89: 369-375, 2003.
10. Sham JST, Tang TCM, Fang Y, Sun L, Qin L-X, Wu Q-L, Xie D and Guan X-Y: Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women. Cancer Genet Cytogenet 133: 39-44, 2002.
11. Taetle R, Aickin M, Panda L, Emerson J, Roe D, Thompson F, Davis J, Trent J and Alberts D: Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases. Genes Chromosomes Cancer 25: 46-52, 1999.
12. Mitelman F (ed.): (ISCN 1995) An International system for human cytogenetic nomenclature. Basel S. Karger, 1995.
13. Panani AD, Ferti A, Malliaros S and Raptis S: Cytogenetic study of 11 gastric adenocarcinomas. Cancer Genet Cytogenet 81: 169-172, 1995.
14. Panani AD, Ferti A, Malliaros S and Raptis S: Gastric cancer with an i(8q) and long survival. Cancer Genet Cytogenet 55: 214-215, 1992.
15. Ochi H, Takeuchi J, Douglass H and Sandberg AA: Trisomy X as a possible initial chromosome change in a gastric cancer. Cancer Genet Cytogenet 12: 57-61, 1984.
16. Mi1telman F, Johansson B and Mertens F: Mitelman Database of Chromosome Aberration in Cancer. (2006) http://cgap.ncijiih.govy Chromosomes/Mitelman.
17. Jacobs PA, Browne C, Gregson N, Joyce C and White H: Estimates of the frequency of chromosome abnormalities detectable in unselected newborns using moderate levels of banding. J Med Genet 29: 103-108, 1992.
18. Betz JL, Behairy AS, Rabionet P, Tirtorahardjo B, Moore MW and Cotter PD: Acquired inv (9): what is its significance? Cancer Genet Cytogenet 160: 76-78, 2005.
19. Wan TS, MA SK and Chan LC: Acquired pericentric inversion of chromosome 9 in essential thrombocythemia. Human Genet 106: 669-670, 2000.
20. Launonen V, Mannermaa A, Stenback F, Kosma VM, Puistola U, Huusko P, Anttila M, Bloigu R, Saarikoski S, Kauppila A and Winqvist R: Loss of heterozigosity at chromosomes 3,6,8,11,16 and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet 722: 49-54, 2000.
21. Stronach EA, Sellar GC, Blenkiron C, Rabiasz GJ, Taylor KJ, Miller EP, Massie CE, Al-Nafussi A, Smyth JF, Porteous DJ and Gabra H: Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression. Cancer Res 63: 8648-8655, 2003.
22. Cabra H, Taylor R, Cohen BB, Lessels A, Eccles DM, Leonard RCF, Smyth JF and Steel CM: Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumors. Br J Cancer 72: 367-375, 1995.
23. Cabra H, Watson JEV, Taylor KJ, MacKay J, Leonard RCF, Steel CM, Porteous DJ and Smyth JF: Definition and refinement of a region of loss of heterozygosity at Ilq23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56: 950-954, 1996.
24. Jenkins PB, Bartelt DJr, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G and Hartmann L: Cytogenetic studies in epithelial ovarian carcinoma. Cancer Genet Cytogenet 71: 76-86,1993.
25. Thompson FH, Emerson J, Alberts D, Liu Y, Guan X-Y, Burgess A, Fox S, Taetle R, Weinstein R, Makar R, Powell D and Trent J: Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 73: 33-45, 1994.
26. Pejovic T, HeimS, Mandahl N, Baldetorp B, Elmfors B, Floderus U-M, Furgyik S, Heim G, Himmelmann A, Willen H and Mitelman F: Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 4: 58-68,1992.